VI
PTLA

Versor Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Versor Investments’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,207,320
Closed -$39.7M – 349
2020
Q2 		$39.7M Buy
+2,207,320
New +$30.7M 3.91% 10

Versor Investments's PTLA Position: Q3 2020 in Review

Versor Investments sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 2,207,320 shares — an estimated $39.7M sold.

Versor Investments first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $39.7M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Versor Investments reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Versor Investments sold 2,207,320 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $39.7M.
  • Versor Investments first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Versor Investments's Portola Pharmaceuticals, Inc. position peaked at $39.7M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Versor Investments's 13F filing for Q3 2020, filed 3 Nov 2020.